I certainly hope you are correct. I've been wakin
Post# of 148282
I cant put my finger on what they could PR aside from an investor call. NP said he would discuss BLA on a call, so I dont think they will PR that.
The UK stuff, I dont think has any legs behind it (atleast not in the immediate future)
Dont have data on trial patients. Not willing to provide data on IND patients as they are reserving for the paper that Dr. Patterson is writing.
So, that leaves enrollment numbers. Possible financing deals. Non binding agreements.... what else?